- $67.37m
- $42.37m
- $19.35m
- 97
- 52
- 51
- 73
2019 October 31st | 2020 October 31st | C2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 25.1 | 20 | 21.3 | 22.2 | 19.4 |
Cost of Revenue | |||||
Gross Profit | 16.4 | 12.7 | 14.8 | 15.2 | 13 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 18.8 | 17.2 | 17.5 | 17.2 | 16.6 |
Operating Profit | 6.25 | 2.8 | 3.84 | 5 | 2.74 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.23 | 3.4 | 5.25 | 5.13 | 3.42 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.23 | 3.34 | 4.95 | 4.3 | 3.12 |
Net Income Before Extraordinary Items | |||||
Net Income | 5.23 | 3.34 | 4.95 | 4.3 | 3.12 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.23 | 3.34 | 4.95 | 4.3 | 3.12 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.489 | 0.296 | 0.437 | 0.381 | 0.276 |